TABLE 1.
Baseline data of intention-to-treat (ITT) and modified intention-to-treat (mITT) populations by assigned arm.
Intention-to-treat |
Modified intention-to-treat |
|||
PEG-ASC | SPMC | PEG-ASC | SPMC | |
(N = 407) | (N = 407) | (N = 279) | (N = 271) | |
n (%) | n (%) | n (%) | n (%) | |
Gender, n (%) | ||||
Male | 216 (53.1%) | 208 (51.1%) | 148 (53.0%) | 149 (55.0%) |
Female | 191 (46.9%) | 199 (48.9%) | 131 (47.0%) | 122 (45.0%) |
Age, years | ||||
Median | 54 | 55 | 54 | 54 |
Range | 18–86 | 18–94 | 18–86 | 18–94 |
IQR | 45–66 | 44–66 | 44–66 | 44–64 |
Previous colonoscopy, n (%) | 51 (12.5%) | 60 (14.7%) | 41 (14.7%) | 42 (15.5%) |
Aim of the colonscopy, n (%) | ||||
Diagnosis | 260 (63.9%) | 259 (63.6%) | 176 (63.1%) | 175 (64.6%) |
Screening | 100 (24.6%) | 102 (25.1%) | 72 (25.8%) | 62 (22.9%) |
Follow-up after colonoscopy | 47 (11.5%) | 46 (11.3%) | 31 (11.1%) | 34 (12.5%) |
Scheme of administration, n (%) | ||||
Standard | 252 (61.9%) | 260 (63.9%) | 181 (64.9%) | 178 (65.7%) |
Split | 155 (38.1%) | 147 (36.1%) | 98 (35.1%) | 93 (34.3%) |